Phase 3 Oral Squamous Cell Carcinoma Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 2Phase 3
A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers
Oral Squamous Cell Carcinoma
Privo Technologies40 enrolled4 locationsNCT05893888
Recruiting
Phase 3
Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma
Oral Squamous Cell Carcinoma (OSCC)Locally Advanced Oral Squamous Cell Carcinoma
Qunxing Li,MD104 enrolled1 locationNCT07371611
Recruiting
Phase 3
Neoadjuvant Immunochemotherapy for LAOSCC
Oral Squamous Cell CarcinomaLocally Advanced Head and Neck Carcinoma
Lai-ping Zhong134 enrolled1 locationNCT06258811
Recruiting
Phase 3
Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma
Oral Squamous Cell Carcinoma
Hospital of Stomatology, Wuhan University309 enrolled3 locationsNCT05798793
Recruiting
Phase 2Phase 3
Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
ChemotherapyOral Squamous Cell CarcinomaNeoadjvant Therapy+1 more
Shanghai Jiao Tong University School of Medicine80 enrolled1 locationNCT05125055